Vitolo, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.312
AS - Asia 7.446
EU - Europa 4.427
SA - Sud America 1.164
OC - Oceania 264
Continente sconosciuto - Info sul continente non disponibili 211
AF - Africa 157
Totale 25.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.902
SG - Singapore 2.266
CN - Cina 2.041
IT - Italia 1.681
HK - Hong Kong 1.001
BR - Brasile 924
VN - Vietnam 684
GB - Regno Unito 588
FI - Finlandia 449
SE - Svezia 365
BD - Bangladesh 364
DE - Germania 320
KR - Corea 311
RU - Federazione Russa 270
AU - Australia 257
FR - Francia 201
CA - Canada 197
ID - Indonesia 136
IN - India 132
AR - Argentina 89
NL - Olanda 85
MX - Messico 69
BG - Bulgaria 60
IQ - Iraq 58
JP - Giappone 58
TR - Turchia 57
AE - Emirati Arabi Uniti 53
UA - Ucraina 48
LT - Lituania 47
PL - Polonia 47
ES - Italia 46
ZA - Sudafrica 45
AT - Austria 43
PK - Pakistan 42
CO - Colombia 38
EC - Ecuador 37
IE - Irlanda 33
UZ - Uzbekistan 31
MA - Marocco 26
MY - Malesia 25
VE - Venezuela 24
KE - Kenya 20
EG - Egitto 19
IL - Israele 19
SA - Arabia Saudita 19
TH - Thailandia 19
AZ - Azerbaigian 17
CL - Cile 17
CR - Costa Rica 17
RS - Serbia 16
TT - Trinidad e Tobago 16
HN - Honduras 15
BE - Belgio 14
GT - Guatemala 14
CH - Svizzera 13
CZ - Repubblica Ceca 13
JM - Giamaica 13
JO - Giordania 13
NI - Nicaragua 13
PH - Filippine 13
RO - Romania 13
SV - El Salvador 13
NP - Nepal 12
OM - Oman 12
TN - Tunisia 12
TW - Taiwan 12
AL - Albania 11
BO - Bolivia 10
PY - Paraguay 10
DZ - Algeria 9
KZ - Kazakistan 9
PE - Perù 9
EE - Estonia 8
PR - Porto Rico 8
NZ - Nuova Zelanda 7
CU - Cuba 6
HU - Ungheria 6
NG - Nigeria 6
PT - Portogallo 6
SC - Seychelles 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
GE - Georgia 5
KG - Kirghizistan 5
LU - Lussemburgo 5
LV - Lettonia 5
UY - Uruguay 5
AM - Armenia 4
CW - ???statistics.table.value.countryCode.CW??? 4
CY - Cipro 4
GP - Guadalupe 4
HR - Croazia 4
IR - Iran 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BN - Brunei Darussalam 3
BS - Bahamas 3
DK - Danimarca 3
Totale 25.719
Salva come PNG Salva come JPEG
Città #
Ashburn 1.663
Santa Clara 1.546
Singapore 1.414
San Jose 1.086
Hong Kong 991
Hefei 891
Council Bluffs 533
Chandler 427
Fairfield 396
Helsinki 390
London 325
Seoul 304
Beijing 285
Nyköping 283
New York 277
Los Angeles 276
The Dalles 271
Ho Chi Minh City 224
Houston 186
Milan 177
Woodbridge 170
Perth 167
Seattle 165
Chicago 153
Hanoi 152
Wilmington 143
Bologna 137
Cambridge 130
Dallas 129
Rome 117
Buffalo 116
San Diego 110
Modena 106
Jakarta 103
São Paulo 102
Munich 98
Lauterbourg 80
Shanghai 79
Princeton 71
Ann Arbor 67
Moscow 63
Southend 63
Columbus 62
Sofia 56
North Bergen 54
Salt Lake City 54
Toronto 52
Kent 50
Montreal 48
Frankfurt am Main 45
Phoenix 44
Sydney 44
Da Nang 43
Atlanta 42
Boardman 42
Tokyo 42
Orem 39
Lappeenranta 36
Johannesburg 34
Naples 34
Nuremberg 34
Denver 33
Reggio Emilia 30
Dublin 29
Tashkent 29
Brooklyn 28
Haiphong 28
Turin 28
Amsterdam 27
Memphis 27
Mexico City 27
Redondo Beach 27
Kilburn 26
Warsaw 26
Rio de Janeiro 25
Guangzhou 24
Miami 24
Chennai 23
Parma 23
Tampa 23
Washington 23
Boston 22
Lakewood 22
Turku 22
Jacksonville 21
Schiffdorf 21
Baghdad 20
Elk Grove Village 20
Saint Augustine 20
Stockholm 20
Belmont 19
Biên Hòa 19
Florence 19
San Francisco 19
Vienna 19
Vilnius 19
Belo Horizonte 18
Brasília 17
Campinas 17
Dubai 17
Totale 16.222
Salva come PNG Salva come JPEG
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 519
Radar-Based Monitoring of Vital Signs: A Tutorial Overview 383
Ibrutinib and Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia: focus on atrial fibrillation and ventricular tachyarrhythmias/sudden cardiac death 362
Oral anticoagulants in patients with atrial fibrillation and end-stage renal disease: Walking the tightrope between thromboembolic and bleeding risk 340
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 339
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 329
Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes 322
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 311
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 300
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 295
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 277
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 275
The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport 275
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 264
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 264
Single-lead VDD pacing: a literature review on short-term and long-term performance 261
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 259
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 252
Red blood cell distribution width in patients undergoing transcatheter aortic valve implantation: Implications for outcomes 247
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 244
Atrial fibrillation burden: Stepping beyond the categorical characterization 239
Progression of Atrial Fibrillation after Cryoablation 239
Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation 229
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 228
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 226
Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation 225
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 223
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology 222
Impact of body mass index on the outcome of elderly patients treated with transcatheter aortic valve implantation 222
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 221
The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years 219
What do we do about atrial high rate episodes? 219
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 213
Technical Suitability of Implantable Cardiac Devices for Recreational Diving 213
Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with atrial fibrillation 213
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 213
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis 209
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 209
Atrial Fibrillation and Other Cardiovascular Factors and the Risk of Dementia: An Italian Case–Control Study 208
Atrial Fibrillation and the Risk of Early‐Onset Dementia: A Systematic Review and Meta‐Analysis 207
Three-Dimensional Automated, Machine-Learning-Based Left Heart Chamber Metrics: Associations with Prevalent Vascular Risk Factors and Cardiovascular Diseases 203
Female sex and stroke in atrial fibrillation: an intriguing relationship 203
Atrial fibrillation before and after transcatheter aortic valve implantation: short- and long-term clinical implications 202
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 201
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 199
Atrial fibrillation in patients with cardiac implantable electronic devices: New perspectives with important clinical implications 197
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 196
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 195
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 195
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 194
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 194
Burden of disease and costs of infections associated with cardiac implantable electronic devices 193
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 191
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 190
Atrial fibrillation in pneumonia: what clinical implications at long-term? 189
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 189
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 188
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 188
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients 185
GESTIONE CLINICA, COMORBIDITÀ ED EVENTI AVVERSI ASSOCIATI IN PAZIENTI CON FIBRILLAZIONE ATRIALE: ANALISI DA UNO STUDIO DI COORTE EUROPEO SU OLTRE 11.000 PAZIENTI 183
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 183
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes 183
Anthropometric parameters and radiation doses during percutaneous coronary procedures 182
Permanent Atrial Fibrillation as the Terminal Stage of a Chronic Disease: Palliative Care Needs to be Considered in Selected Patients with Markedly Impaired Quality of Life 181
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 180
Clinical phenotype classification of atrial fibrillation patients using cluster analysis and associations with trial-adjudicated outcomes 180
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 176
Clinical decisions for appropriate management of patients with atrial fibrillation 176
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 175
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 172
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 171
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 171
Grey zones in the practice of permanent cardiac pacing: The case of preventive pacing for improving rhythm control in atrial fibrillation 171
Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: A systematic review and meta-analysis of 81,462 patients 170
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 167
Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort 166
Biomarkers in atrial fibrillation: A constant search for simplicity, practicality, and cost-effectiveness 165
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 163
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 162
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 161
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry 160
Cardiac resynchronization therapy: Need to synchronize patients and device longevities with comorbidities 158
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe 157
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 157
COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease 155
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 152
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 151
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 150
Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry 148
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry 148
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 145
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes 144
Red cell distribution width and patient outcome in cardiovascular disease: A ‘’real-world” analysis 143
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 143
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry 142
Tailored oral anticoagulant prescription in patients with atrial fibrillation: Use and misuse of clinical risk prediction scores 141
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry 139
How did COVID-19 affect medical and cardiology journals? A pandemic in literature 138
CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex 137
Cardiomyopathy associated with long-term right ventricular pacing: an intriguing clinical issue 137
Totale 20.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.548
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022954 0 0 0 0 39 102 30 57 128 99 244 255
2022/20231.454 155 154 119 69 125 175 49 149 206 44 130 79
2023/20241.648 52 86 107 170 283 238 123 213 38 51 87 200
2024/20255.807 131 91 299 364 991 780 546 346 564 414 618 663
2025/202610.736 744 437 901 1.119 1.060 600 1.624 573 1.180 938 890 670
2026/20274.026 453 1.162 863 1.488 60 0 0 0 0 0 0 0
Totale 25.981